Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 23, 2026 5.922
October 22, 2026 6.042
October 21, 2026 6.104
October 20, 2026 6.138
October 19, 2026 6.208
October 16, 2026 6.236
October 15, 2026 6.177
October 14, 2026 6.119
October 13, 2026 6.198
October 12, 2026 6.186
October 09, 2026 6.176
October 08, 2026 5.898
October 07, 2026 5.887
October 06, 2026 5.880
October 05, 2026 5.960
October 02, 2026 5.94
October 01, 2026 5.907
September 30, 2026 5.950
September 29, 2026 5.982
September 28, 2026 5.842
September 25, 2026 5.889
September 24, 2026 6.044
September 23, 2026 5.862
September 22, 2026 5.938
September 21, 2026 6.020
Date Value
September 18, 2026 5.857
September 17, 2026 5.889
September 16, 2026 5.790
September 15, 2026 5.898
September 14, 2026 5.818
September 11, 2026 5.560
September 10, 2026 5.462
September 09, 2026 5.537
September 08, 2026 5.524
September 04, 2026 5.464
September 03, 2026 5.503
September 02, 2026 5.634
September 01, 2026 5.438
August 31, 2026 5.417
August 28, 2026 5.476
August 27, 2026 5.653
August 26, 2026 5.698
August 25, 2026 5.725
August 24, 2026 5.549
August 21, 2026 5.611
August 20, 2026 5.531
August 19, 2026 5.630
August 18, 2026 5.497
August 17, 2026 5.479
August 14, 2026 5.525

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Bristol Myers Squibb Co. 5.628
Merck & Co., Inc. 8.552
RedHill Biopharma Ltd. 0.0192
AstraZeneca PLC 11.24
Eli Lilly & Co. 35.39

Price to Book Value Related Metrics